Around 500 protein researchers are expected in Würzburg in late 2026. The Proteomics Forum 2026 will be held here alongside the 15th EuPA Congress. Conference abstracts may be submitted until 30 June; the registration deadline is 15 September.

A new drug candidate has been shown to alleviate symptoms of Huntington's disease and extend lifespan – at least in animal studies. There is some evidence to suggest that these results may also apply to humans.

Disorder brings more life to the forest: Birds and bats react to this in different ways. This is shown by a new study from the University of Würzburg’s Biocenter.